Results 141 to 150 of about 122,282 (250)
Retinoblastoma: a study of natural history and prognosis of 268 cases. [PDF]
, 1975 E L Lennox, G J Draper, B M Sanders
openalex +1 more source
International Journal of Cancer, Volume 157, Issue 1, Page 103-115, 1 July 2025.What's new? Because of widespread use and resistance to degradation, per‐ and polyfluoroalkyl substances (PFAS) are ubiquitous in the environment. For young children, owing in part to crawling and hand‐to‐mouth behaviors, PFAS exposure is unique. Here, the authors investigated the risk of childhood leukemia in relation to PFAS found in settled dust ...
Catherine Metayer +6 more
wiley +1 more source
Retinoblastoma: The Evidence Does Matter
Cellular Oncology, 2009 Nadia L. Prigoda-Leea +6 more
doaj +1 more source
Incidence of retinoblastoma in the Bantu of South Africa. [PDF]
, 1976 Jeffrey Freedman, Lior Goldberg
openalex +1 more source
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
MedComm, Volume 6, Issue 7, July 2025.Tumor cells adapt to nutrient‐poor environments by altering metabolism to acquire essential nutrients. They convert glutamine into glutamate and α‐ketoglutarate, supporting mTOR activation and sugar biosynthesis. Disruption of mTORC1 signaling is linked to disease, while glutamine and leucine activation promotes cell growth and inhibits autophagy ...
Mudasir A. Kumar +10 more
wiley +1 more source
Retinoblastoma occurring in four successive generations. [PDF]
, 1976 C. Migdal
openalex +1 more source
Transforming Growth Factor‐β Pathway: Biological Functions and Therapeutic Targets
MedComm, Volume 6, Issue 7, July 2025.Natural compounds modulate the TGF‐β pathway, which acts as both a tumor suppressor and promoter during cancer progression. Agents such as ginsenosides, halofuginone, and EGCG influence cell proliferation, apoptosis, and angiogenesis. These bioactive molecules may complement standard therapies, highlighting the need for advanced formulations ...
Reham Hassan Mekky +9 more
wiley +1 more source
Late Mortality Among Survivors of Childhood Cancer in Canada: A Retrospective Cohort Study
Pediatric Blood &Cancer, Volume 72, Issue 7, July 2025.ABSTRACT Background Children with cancer face an increased risk of complications and death beyond the 5‐year survival mark. National surveillance efforts facilitate the systematic tracking of long‐term health outcomes, including treatment‐related complications and late mortality, among childhood cancer survivors.
Katherine McKenzie +5 more
wiley +1 more source